BAM
PRTK

Belpointe Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Belpointe Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,065
Closed -$228K – 502
2017
Q3 		$228K Buy
+9,065
New +$228K 0.05% 377